• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Aridis Pharmaceuticals(ARDS.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2023 Q3 Earning Release (USD) Revenue 417 K, Net Income -83 K, EPS -0.0022

Sep14
Earning Release(EST)

FY2023 Q2 Earning Release (USD) Revenue 19.65 M, Net Income 12.14 M, EPS 0.33

Jun8
Earning Release(EST)

FY2023 Q1 Earning Release (USD) Revenue 1.082 M, Net Income -6.816 M, EPS -0.2241

View More

DolphinResearch

Hesai: Tesla 'Disdain'? Still Growing Wildly Towards the Sun
11-11 22:16

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More